Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amarin Corp PLC

0.4486
+0.01593.67%
Volume:898.45K
Turnover:406.48K
Market Cap:185.80M
PE:-2.24
High:0.4636
Open:0.4390
Low:0.4329
Close:0.4327
Loading ...

Company Profile

Company Name:
Amarin Corp PLC
Exchange:
NASDAQ
Establishment Date:
1989
Employees:
- -
Office Location:
Iconic Offices, The Greenway,Block C Ardilaun Court,St Stephens Green,Dublin,Co. Dublin,Ireland
Zip Code:
112-114
Fax:
- -
Introduction:
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Directors

Name
Position
Odysseas Kostas
Director and Chairman of the Board
Adam M. Berger
Director
Diane Sullivan
Director
Erin Enright
Director
Geraldine Murphy
Director
Keith L. Horn
Director
Louis Sterling III
Director
Mark DiPaolo
Director
Oliver O'Connor
Director
Patrice Bonfiglio
Director
Paul Cohen
Director

Shareholders

Name
Position
Aaron D. Berg
Interim President and Chief Executive Officer, Executive Vice President, President-U.S.
Thomas C. Reilly
Chief Financial Officer and Chief Accounting Officer
Steven B. Ketchum
President of Research and Development, Executive Vice President and Chief Scientific Officer